Adverse events, n (%) | |
---|---|
Minimal intervention* | |
Agitation | 6 (0.4) |
Emesis | 5 (0.3) |
Emergence phenomena | 3 (0.2) |
Hypotension—no intervention | 7 (0.4) |
Hypoxia—no intervention | 1 (0.1) |
Tachycardia | 1 (0.1) |
Other: subcutaneous injection of sedative (n=1), unknown (n=1) | 2 (0.1) |
Total minimal intervention | 25 (1.5) |
Minor intervention* | |
Airway obstruction—stimulate | 3 (0.2) |
Airway obstruction—airway repositioning | 27 (1.6) |
Apnoea—stimulate | 23 (1.3) |
Hypoxia—stimulate | 13 (0.8) |
Hypoxia—airway repositioning | 8 (0.5) |
Hypoxia—oxygen administration | 25 (1.5) |
Total minor intervention | 99 (5.8) |
Moderate interventions* | |
Airway obstruction—oral airway insertion | 2 (0.1) |
Apnoea—bag valve mask ventilation | 25 (1.5) |
Apnoea—reversal agent administration | 2 (0.1) |
Hypotension—fluid bolus | 20 (1.2) |
Hypoxia—bag valve mask ventilation | 19 (1.1) |
Hypoxia—reversal agent administration | 2 (0.1) |
Total moderate intervention | 70 (4.1) |
Sentinel interventions | 0 (0) |
Total number of adverse events | 194 (11.3) |
Total number of cases with adverse events† | 181 (10.6) |
*Interventions classified according to World SIVA adverse sedation reporting tool 2012.
†Some patients had more than one adverse event.